SCHEMBL27384259

SCHEMBL27384259

CCc1ccc2cc(CNC(=O)N3CCCCC3)[nH]c2c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 3/20 0.48
▸ RAB9A P51151 2/20 0.48
▸ NPC1 O15118 1/20 0.48
▸ MMP9 P14780 1/20 0.44
▸ DAO P14920 1/20 0.43
▸ MAPK1 P28482 1/20 0.42
▸ METTL3 Q86U44 9/20 0.42
▸ METTL14 Q9HCE5 9/20 0.42
▸ POLB P06746 1/20 0.42
▸ TPSAB1 Q15661 1/20 0.40
▸ TPSD1 Q9BZJ3 1/20 0.40
▸ TPSG1 Q9NRR2 1/20 0.40
▸ MEN1 O00255 2/20 0.39
▸ MAPT P10636 2/20 0.39
▸ KDM4E B2RXH2 2/20 0.39
▸ ALDH1A1 P00352 1/20 0.39
▸ CASP1 P29466 1/20 0.39
▸ CASP7 P55210 1/20 0.39
▸ HSD17B10 Q99714 1/20 0.39
▸ TP53 P04637 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27384257 0.84 RAB9A (0.50) KMT2ARAB9ANPC1MAPK1MEN1
SCHEMBL27384644 0.83 MAPK1 (0.46) KMT2ARAB9ANPC1MAPK1METTL3
SCHEMBL27247001 0.81 MTNR1A (0.56) KMT2ARAB9ANPC1MEN1KDM4E
SCHEMBL27382485 0.80 DAO (0.51) KMT2ARAB9ADAOMETTL3METTL14
SCHEMBL27384640 0.79 MAPK1 (0.46) KMT2ARAB9ANPC1MAPK1TPSAB1
SCHEMBL27384652 0.79 SMN1; SMN2 (0.41) RAB9AMAPK1
SCHEMBL27382491 0.79 MTNR1A (0.50) DAOMETTL3METTL14KDM4EALDH1A1
SCHEMBL27384519 0.78 DAO (0.49) RAB9ADAOMETTL3METTL14KDM4E
SCHEMBL27383634 0.77 DAO (0.46) RAB9ADAOMETTL3METTL14
SCHEMBL27383806 0.76 DAO (0.45) DAOMETTL3METTL14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024081748-A2 INHIBITORS OF SOLUTE CARRIER FAMILY 6A MEMBER 19 (SLC6A19) AND METHODS OF USE THEREOF MAZE THERAPEUTICS, INC. (US) 2024-04-18 — — WO disclosed
Send feedback